TP53 and endometrial carcinoma: When the molecular categorization is applied to high-grade and/or high-risk endometrial carcinomas, it reveals that individuals with POLEmut tumors, which have a great prognosis, and those with p53-abnormal (p53abn) tumors, which have a bad prognosis, have different outcomes.